Publication date | Issuer | Person discharging managerial responsibilities | Position | Closely associated | Nature of transaction | Instrument name | Intrument type | ISIN | Transaction date | Volume | Unit | Price | Currency | Status | Details |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
01/03/2024 | Xvivo Perfusion Aktiebolag | Kristoffer Nordström | Chief Financial Officer (CFO) | Acquisition | Xvivo Perfusion AB | Share | SE0004840718 | 29/02/2024 | 335 | Quantity | 264.00 | SEK | Notification | ||
26/01/2024 | Xvivo Perfusion | Gösta Johannesson | Chairman of the Board of Directors | Acquisition | Xvivo Perfusion AB | Share | SE0004840718 | 25/01/2024 | 500 | Quantity | 290.00 | SEK | Notification | ||
26/01/2024 | Xvivo Perfusion | Gösta Johannesson | Chairman of the Board of Directors | Acquisition | Xvivo Perfusion AB | Share | SE0004840718 | 26/01/2024 | 500 | Quantity | 272.00 | SEK | Notification | ||
14/11/2023 | Xvivo Perfusion Aktiebolag | Gösta Johannesson | Chairman of the Board of Directors | Yes | Acquisition | Xvivo Perfusion AB | Share | SE0004840718 | 14/11/2023 | 500 | Quantity | 249.00 | SEK | Notification | |
25/04/2023 | Xvivo Perfusion Aktiebolag | Lars Henriksson | Member of the Board of Directors | Acquisition | Xvivo Perfusion AB | Share | SE0004840718 | 24/04/2023 | 400 | Quantity | 268.00 | SEK | Notification | ||
02/11/2022 | Xvivo Perfusion Aktiebolag | Gösta Johannesson | Chairman of the Board of Directors | Acquisition | Xvivo Perfusion AB | Share | SE0004840718 | 01/11/2022 | 1,000 | Quantity | 166.50 | SEK | Notification | ||
02/11/2022 | Xvivo Perfusion Aktiebolag | Gösta Johannesson | Chairman of the Board of Directors | Acquisition | Xvivo Perfusion AB | Share | SE0004840718 | 02/11/2022 | 200 | Quantity | 170.00 | SEK | Notification | ||
19/08/2022 | Xvivo Perfusion Aktiebolag | Dag Andersson Tilk | Chief Executive Officer (CEO)/Managing Directory | Acquisition | Xvivo Perfusion AB | Share | SE0004840718 | 19/08/2022 | 499 | Quantity | 199.80 | SEK | Notification | ||
01/06/2022 | Xvivo Perfusion Aktiebolag | Dag Andersson Tilk | Chief Executive Officer (CEO)/Managing Directory | Acquisition | XVIVO 2022/2025 | Subcription warrant | 01/06/2022 | 20,000 | Quantity | 17.92 | SEK | Notification | |||
31/05/2022 | XVIVO Perfusion AB | Christoffer Björn Rosenblad | Deputy CEO/Deputy Managing Director | Acquisition | XVIVO 2022/2025 | Subcription warrant | 31/05/2022 | 10,000 | Quantity | 17.92 | SEK | Notification |